US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mural Oncology

2.04

0.0000

Volume:- -

Turnover:259.92K

Market Cap:35.38M

PE:-0.29

High:2.04

Open:2.04

Low:2.04

Close:2.04

52wk High:4.74

52wk Low:0.9500

Shares:17.34M

Float Shares:14.04M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.9259

EPS(LYR):-7.5799

ROE:-103.87%

ROA:-49.05%

PB:0.64

PE(LYR):-0.27

Loading ...

Overview Company News Filings

XOMA Royalty Completes Acquisition of Mural Oncology

MT Newswires Live

Press Release: Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition

NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM

Press Release: Mural Oncology Announces Sanction of the Scheme by the High Court

Mural Oncology Sets Final Cash Consideration at $2.035 Per Share in XOMA Royalty Acquisition

Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

THOMSON REUTERS

Mural Oncology Plc - Total Cash Consideration of $2.035 per Share

THOMSON REUTERS

Mural Oncology Approves Acquisition by XRA 5 Corp.

Mural Oncology shareholders approve acquisition by XRA 5 Corp.

Mural Oncology plc Held Shareholder Meeting

Press Release: Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

Mural Oncology plc Announces Date for Shareholder Scheme Meeting

Press Release: Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

Mural Oncology Plc Announces Acquisition by XOMA Royalty Corporation

Mural Oncology plc Files Initial Statement of Beneficial Ownership; Trium Capital LLP Named as 10% Owner

Mural Oncology Announces Agreement to be Acquired by XOMA Royalty for Cash Consideration

Mural Oncology Announces Entry Into Agreement to Be Acquired by Xra 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty for Between $2.035 and $2.24 in Cash per Share

THOMSON REUTERS

Mural Oncology Plc - Acquisition Values Mural at About $36.2 Mln

THOMSON REUTERS

Mural Oncology Q2 EPS $(2.78) Misses $(1.51) Estimate

Mural Oncology Reports Q2 2025 Net Loss of $48 Million, Up from $31.6 Million in Q2 2024 Due to Restructuring Charges

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MURA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MURA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MURA\",,,,,undefined,":{"symbol":"MURA","market":"US","secType":"STK","nameCN":"Mural Oncology","latestPrice":2.04,"timestamp":1764882000000,"preClose":2.04,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":14041645,"shares":17344486,"eps":-6.925897,"marketStatus":"Halted","change":0,"latestTime":"12-04 16:00:00 EST","open":2.04,"high":2.04,"low":2.04,"amount":259917.0045075,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.925897,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.04,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MURA\",,,,,undefined,":{"symbol":"MURA","floatShares":14041645,"roa":"-49.05%","roe":"-103.87%","lyrEps":-7.5799,"shares":17344486,"dividePrice":0,"high":2.04,"amplitude":0,"preClose":2.04,"low":2.04,"week52Low":0.95,"pbRate":"0.64","week52High":4.74,"institutionHeld":0,"latestPrice":2.04,"eps":-6.925897,"divideRate":0,"volume":0,"delay":0,"ttmEps":-6.925897,"open":2.04,"prevYearClose":3.22,"prevWeekClose":2.03,"prevMonthClose":2.03,"prevQuarterClose":2.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MURA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-08","symbol":"MURA","reason":null,"defaultRemindTime":1765204200000,"announcedDate":"2025-12-02","type":"delisting","dateTimestamp":1765170000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MURA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MURA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1742878800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MURA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MURA","date":"2025-12-05","current":-0.294547,"percent":0.730603,"low":-0.567064,"twenty":-0.398359,"median":-0.332486,"eighty":-0.278335,"high":-0.133414,"avg":-0.335595,"sd":0.075781,"marketCap":35382751},"quantilePoints":[{"date":"2024-01-05","current":-0.481599,"twenty":-0.478881,"median":-0.474804,"eighty":-0.470727,"marketCap":94630786},{"date":"2024-01-12","current":-0.410251,"twenty":-0.486355,"median":-0.471406,"eighty":-0.445585,"marketCap":80611410},{"date":"2024-01-19","current":-0.3423,"twenty":-0.481599,"median":-0.439979,"eighty":-0.393263,"marketCap":67259623},{"date":"2024-01-26","current":-0.394962,"twenty":-0.471406,"median":-0.400483,"eighty":-0.374577,"marketCap":77607258},{"date":"2024-02-02","current":-0.377974,"twenty":-0.468009,"median":-0.394962,"eighty":-0.374577,"marketCap":74269311},{"date":"2024-02-09","current":-0.361836,"twenty":-0.439979,"median":-0.387742,"eighty":-0.372878,"marketCap":71098262},{"date":"2024-02-16","current":-0.422992,"twenty":-0.422992,"median":-0.393263,"eighty":-0.372878,"marketCap":83114870},{"date":"2024-02-23","current":-0.394962,"twenty":-0.419594,"median":-0.394962,"eighty":-0.374237,"marketCap":77607258},{"date":"2024-03-01","current":-0.449322,"twenty":-0.440489,"median":-0.397934,"eighty":-0.375256,"marketCap":88288687},{"date":"2024-03-08","current":-0.463762,"twenty":-0.455438,"median":-0.398359,"eighty":-0.376785,"marketCap":91125942},{"date":"2024-03-15","current":-0.409401,"twenty":-0.455438,"median":-0.402181,"eighty":-0.377804,"marketCap":80444513},{"date":"2024-03-22","current":-0.371179,"twenty":-0.454589,"median":-0.401757,"eighty":-0.376785,"marketCap":72934133},{"date":"2024-03-28","current":-0.403798,"twenty":-0.451361,"median":-0.400058,"eighty":-0.375086,"marketCap":83766622},{"date":"2024-04-05","current":-0.375246,"twenty":-0.449322,"median":-0.398359,"eighty":-0.374978,"marketCap":77843730},{"date":"2024-04-12","current":-0.350774,"twenty":-0.445245,"median":-0.39751,"eighty":-0.372198,"marketCap":72766965},{"date":"2024-04-19","current":-0.291224,"twenty":-0.441508,"median":-0.394962,"eighty":-0.366932,"marketCap":60413503},{"date":"2024-04-26","current":-0.287961,"twenty":-0.440319,"median":-0.393263,"eighty":-0.354313,"marketCap":59736601},{"date":"2024-05-03","current":-0.311618,"twenty":-0.439979,"median":-0.38392,"eighty":-0.342979,"marketCap":64644141},{"date":"2024-05-10","current":-0.309986,"twenty":-0.43845,"median":-0.382221,"eighty":-0.327769,"marketCap":64305690},{"date":"2024-05-17","current":-0.343069,"twenty":-0.428768,"median":-0.378823,"eighty":-0.318307,"marketCap":65833885},{"date":"2024-05-24","current":-0.316611,"twenty":-0.420444,"median":-0.375426,"eighty":-0.318307,"marketCap":60756722},{"date":"2024-05-31","current":-0.295445,"twenty":-0.417386,"median":-0.374577,"eighty":-0.316082,"marketCap":56694991},{"date":"2024-06-07","current":-0.294563,"twenty":-0.413309,"median":-0.372878,"eighty":-0.310639,"marketCap":56525752},{"date":"2024-06-14","current":-0.291035,"twenty":-0.410081,"median":-0.371179,"eighty":-0.308355,"marketCap":55848797},{"date":"2024-06-21","current":-0.286626,"twenty":-0.409401,"median":-0.368234,"eighty":-0.301829,"marketCap":55002603},{"date":"2024-06-28","current":-0.270751,"twenty":-0.409061,"median":-0.366932,"eighty":-0.301173,"marketCap":51956305},{"date":"2024-07-05","current":-0.264578,"twenty":-0.407601,"median":-0.361535,"eighty":-0.298647,"marketCap":50771634},{"date":"2024-07-12","current":-0.28839,"twenty":-0.40373,"median":-0.353221,"eighty":-0.295445,"marketCap":55341081},{"date":"2024-07-15","current":-0.28839,"twenty":-0.403661,"median":-0.351997,"eighty":-0.295445,"marketCap":55341081},{"date":"2024-08-02","current":-0.30691,"twenty":-0.403593,"median":-0.350774,"eighty":-0.295445,"marketCap":58895095},{"date":"2024-08-09","current":-0.28839,"twenty":-0.402946,"median":-0.34384,"eighty":-0.294206,"marketCap":55341081},{"date":"2024-08-16","current":-0.309698,"twenty":-0.402097,"median":-0.3423,"eighty":-0.293345,"marketCap":53669674},{"date":"2024-08-23","current":-0.322479,"twenty":-0.400738,"median":-0.337815,"eighty":-0.294206,"marketCap":55884613},{"date":"2024-08-30","current":-0.320512,"twenty":-0.399365,"median":-0.334277,"eighty":-0.294563,"marketCap":55543853},{"date":"2024-09-06","current":-0.314613,"twenty":-0.398685,"median":-0.332486,"eighty":-0.294916,"marketCap":54521574},{"date":"2024-09-13","current":-0.309698,"twenty":-0.398359,"median":-0.332045,"eighty":-0.295445,"marketCap":53669674},{"date":"2024-09-20","current":-0.340176,"twenty":-0.398359,"median":-0.331604,"eighty":-0.295445,"marketCap":58951452},{"date":"2024-09-27","current":-0.2979,"twenty":-0.398019,"median":-0.327395,"eighty":-0.295798,"marketCap":51625115},{"date":"2024-10-04","current":-0.314613,"twenty":-0.396762,"median":-0.323462,"eighty":-0.296327,"marketCap":54521574},{"date":"2024-10-11","current":-0.336243,"twenty":-0.395369,"median":-0.327395,"eighty":-0.296327,"marketCap":58269932},{"date":"2024-10-18","current":-0.362789,"twenty":-0.394962,"median":-0.331327,"eighty":-0.296956,"marketCap":62870190},{"date":"2024-10-25","current":-0.343125,"twenty":-0.394282,"median":-0.332398,"eighty":-0.2979,"marketCap":59462592},{"date":"2024-10-31","current":-0.350008,"twenty":-0.393263,"median":-0.332486,"eighty":-0.298033,"marketCap":60655251},{"date":"2024-11-08","current":-0.33231,"twenty":-0.391781,"median":-0.332486,"eighty":-0.298629,"marketCap":57588412},{"date":"2024-11-15","current":-0.387645,"twenty":-0.387286,"median":-0.33396,"eighty":-0.298901,"marketCap":59610428},{"date":"2024-11-22","current":-0.374316,"twenty":-0.385465,"median":-0.33526,"eighty":-0.298973,"marketCap":57560786},{"date":"2024-11-29","current":-0.443181,"twenty":-0.393263,"median":-0.336243,"eighty":-0.298973,"marketCap":68150604},{"date":"2024-12-06","current":-0.455399,"twenty":-0.39564,"median":-0.339193,"eighty":-0.299866,"marketCap":70029443},{"date":"2024-12-13","current":-0.415413,"twenty":-0.398359,"median":-0.339541,"eighty":-0.300736,"marketCap":63880516},{"date":"2024-12-20","current":-0.348769,"twenty":-0.398359,"median":-0.340176,"eighty":-0.301829,"marketCap":53632305},{"date":"2024-12-27","current":-0.353212,"twenty":-0.398359,"median":-0.340176,"eighty":-0.301829,"marketCap":54315519},{"date":"2025-01-03","current":-0.355433,"twenty":-0.398359,"median":-0.34173,"eighty":-0.302962,"marketCap":54657126},{"date":"2025-01-10","current":-0.405416,"twenty":-0.398359,"median":-0.343097,"eighty":-0.304593,"marketCap":62343284},{"date":"2025-01-17","current":-0.409859,"twenty":-0.401077,"median":-0.344248,"eighty":-0.306233,"marketCap":63026498},{"date":"2025-01-24","current":-0.435406,"twenty":-0.40373,"median":-0.345715,"eighty":-0.306728,"marketCap":66954979},{"date":"2025-01-31","current":-0.418745,"twenty":-0.408369,"median":-0.346075,"eighty":-0.30678,"marketCap":64392927},{"date":"2025-02-07","current":-0.492053,"twenty":-0.409859,"median":-0.34988,"eighty":-0.307074,"marketCap":75665959},{"date":"2025-02-14","current":-0.473171,"twenty":-0.413191,"median":-0.351865,"eighty":-0.307731,"marketCap":72762299},{"date":"2025-02-21","current":-0.468728,"twenty":-0.415413,"median":-0.353212,"eighty":-0.307731,"marketCap":72079085},{"date":"2025-02-28","current":-0.406527,"twenty":-0.418745,"median":-0.354323,"eighty":-0.308355,"marketCap":62514088},{"date":"2025-03-07","current":-0.39653,"twenty":-0.416524,"median":-0.35567,"eighty":-0.308355,"marketCap":60976856},{"date":"2025-03-14","current":-0.486438,"twenty":-0.418745,"median":-0.357655,"eighty":-0.308355,"marketCap":62514088},{"date":"2025-03-21","current":-0.518803,"twenty":-0.425409,"median":-0.358364,"eighty":-0.309698,"marketCap":66673486},{"date":"2025-03-28","current":-0.180978,"twenty":-0.428742,"median":-0.357873,"eighty":-0.308355,"marketCap":23258192},{"date":"2025-04-04","current":-0.164891,"twenty":-0.425409,"median":-0.357272,"eighty":-0.30691,"marketCap":21190797},{"date":"2025-04-11","current":-0.133414,"twenty":-0.422992,"median":-0.355433,"eighty":-0.303717,"marketCap":17145595},{"date":"2025-04-17","current":-0.32442,"twenty":-0.42226,"median":-0.354323,"eighty":-0.301829,"marketCap":41692464},{"date":"2025-04-25","current":-0.353912,"twenty":-0.421188,"median":-0.355237,"eighty":-0.303339,"marketCap":45482688},{"date":"2025-05-02","current":-0.349891,"twenty":-0.419189,"median":-0.353912,"eighty":-0.305469,"marketCap":44965839},{"date":"2025-05-09","current":-0.347209,"twenty":-0.418745,"median":-0.353217,"eighty":-0.30656,"marketCap":44621273},{"date":"2025-05-16","current":-0.333407,"twenty":-0.416968,"median":-0.353212,"eighty":-0.306743,"marketCap":43587576},{"date":"2025-05-23","current":-0.363252,"twenty":-0.415635,"median":-0.353567,"eighty":-0.306878,"marketCap":47489422},{"date":"2025-05-30","current":-0.348722,"twenty":-0.415413,"median":-0.353217,"eighty":-0.307403,"marketCap":45589845},{"date":"2025-06-06","current":-0.339476,"twenty":-0.415373,"median":-0.352957,"eighty":-0.307731,"marketCap":44381024},{"date":"2025-06-13","current":-0.334192,"twenty":-0.414053,"median":-0.351901,"eighty":-0.308105,"marketCap":43690268},{"date":"2025-06-20","current":-0.326267,"twenty":-0.413191,"median":-0.350402,"eighty":-0.308355,"marketCap":42654136},{"date":"2025-06-27","current":-0.327587,"twenty":-0.412747,"median":-0.349891,"eighty":-0.308355,"marketCap":42826824},{"date":"2025-07-03","current":-0.340797,"twenty":-0.411715,"median":-0.34988,"eighty":-0.308624,"marketCap":44553712},{"date":"2025-07-11","current":-0.328248,"twenty":-0.410173,"median":-0.348636,"eighty":-0.309698,"marketCap":42913169},{"date":"2025-07-18","current":-0.328908,"twenty":-0.409859,"median":-0.347401,"eighty":-0.309698,"marketCap":42999513},{"date":"2025-07-25","current":-0.324946,"twenty":-0.409859,"median":-0.346645,"eighty":-0.309698,"marketCap":42481447},{"date":"2025-08-01","current":-0.297206,"twenty":-0.409767,"median":-0.346075,"eighty":-0.309698,"marketCap":38854982},{"date":"2025-08-08","current":-0.197788,"twenty":-0.40927,"median":-0.345895,"eighty":-0.308355,"marketCap":29104923},{"date":"2025-08-15","current":-0.208384,"twenty":-0.408709,"median":-0.344759,"eighty":-0.30678,"marketCap":30664115},{"date":"2025-08-22","current":-0.243703,"twenty":-0.408369,"median":-0.34331,"eighty":-0.304155,"marketCap":35861423},{"date":"2025-08-29","current":-0.243709,"twenty":-0.407416,"median":-0.343069,"eighty":-0.30004,"marketCap":35862275},{"date":"2025-09-05","current":-0.243709,"twenty":-0.406527,"median":-0.342118,"eighty":-0.298883,"marketCap":35862275},{"date":"2025-09-12","current":-0.243709,"twenty":-0.406527,"median":-0.340797,"eighty":-0.297206,"marketCap":35862275},{"date":"2025-09-19","current":-0.244886,"twenty":-0.405416,"median":-0.340176,"eighty":-0.295445,"marketCap":36035523},{"date":"2025-09-26","current":-0.246064,"twenty":-0.404305,"median":-0.340176,"eighty":-0.294563,"marketCap":36208771},{"date":"2025-10-03","current":-0.243709,"twenty":-0.403798,"median":-0.339541,"eighty":-0.291224,"marketCap":35862275},{"date":"2025-10-10","current":-0.244886,"twenty":-0.403456,"median":-0.339193,"eighty":-0.291035,"marketCap":36035523},{"date":"2025-10-17","current":-0.243709,"twenty":-0.403195,"median":-0.339166,"eighty":-0.28839,"marketCap":35862275},{"date":"2025-10-24","current":-0.246064,"twenty":-0.402606,"median":-0.338155,"eighty":-0.284862,"marketCap":36208771},{"date":"2025-10-31","current":-0.247241,"twenty":-0.402084,"median":-0.336834,"eighty":-0.276924,"marketCap":36382019},{"date":"2025-11-07","current":-0.303295,"twenty":-0.401757,"median":-0.336167,"eighty":-0.272261,"marketCap":36122147},{"date":"2025-11-14","current":-0.304022,"twenty":-0.400058,"median":-0.33526,"eighty":-0.274279,"marketCap":36208771},{"date":"2025-11-21","current":-0.305477,"twenty":-0.398903,"median":-0.334234,"eighty":-0.276924,"marketCap":36382019},{"date":"2025-11-28","current":-0.295295,"twenty":-0.398468,"median":-0.333525,"eighty":-0.276924,"marketCap":35169285},{"date":"2025-12-05","current":-0.297087,"twenty":-0.398359,"median":-0.332486,"eighty":-0.278335,"marketCap":35382751}],"updateTime":1770550976298},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MURA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589381343","title":"XOMA Royalty Completes Acquisition of Mural Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381343","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589381343?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:39","pubTimestamp":1764945551,"startTime":"0","endTime":"0","summary":"XOMA Royalty  said Friday it has completed its previously announced acquisition of Mural Oncology .The acquisition was approved by Mural shareholders on Oct. 24 and later was sanctioned by the Irish High Court on Dec. 3, XOMA Royalty said.Mural Oncology shares will be delisted from Nasdaq and deregistered, XOMA Royalty said.Price: 31.13, Change: +0.13, Percent Change: +0.42","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MURA","XOMA","BK4139"],"gpt_icon":0},{"id":"2589489219","title":"Press Release: Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2589489219","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589489219?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:45","pubTimestamp":1764938700,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass. and DUBLIN, Dec. 05, 2025  -- Mural Oncology plc,   announces that the scheme of arrangement between Mural and its shareholders under Chapter 1 of Part 9 of the Companies Act 2014  pursuant to which XRA 5 Corp. , a wholly-owned subsidiary of XOMA Royalty Corporation   will acquire the entire issued and to be issued share capital of Mural, became effective today, 5 December 2025 .Distribution of cheques and crediting of DTC participant accounts for the cash consideration paid by Sub to Scheme Shareholders under the terms of the Scheme is expected to commence as soon as practicable following the Effective Date, with DTC participant accounts expected to be credited and the distribution of cheques expected to be complete as soon as practicable. In accordance with the requirements of the Irish Takeover Rules, all consideration paid by Sub to Scheme Shareholders under the terms of the Scheme will be distributed by no later than 19 December 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2589856034","title":"NASDAQ TRADE HALT  TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2589856034","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589856034?lang=en_us&edition=fundamental","pubTime":"2025-12-05 08:50","pubTimestamp":1764895800,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nAQN2LC654:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2588024172","title":"Press Release: Mural Oncology Announces Sanction of the Scheme by the High Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2588024172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588024172?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:30","pubTimestamp":1764797400,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass. and DUBLIN, Dec. 03, 2025  -- Mural Oncology plc,   announces that the High Court of Ireland has today sanctioned the scheme of arrangement between Mural and its shareholders under Chapter 1 of Part 9 of the Companies Act 2014  pursuant to which XRA 5 Corp. , a wholly-owned subsidiary of XOMA Royalty Corporation  , will acquire the entire issued and to be issued share capital of Mural .The Scheme and the Acquisition will become effective on delivery of the Court Order to the Irish Registrar of Companies.Delivery of the Court Order to the Irish Registrar of Companies is expected to occur, and the Acquisition is expected to become effective, on 5 December 2025 . Accordingly, 4 December 2025 is expected to be the last date on which trading of Mural Shares on the Nasdaq will occur. Cancellation of the admission of Mural Shares to trading on the Nasdaq Global Market is expected to occur with effect from 8.00 pm  on 4 December 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2586250273","title":"Mural Oncology Sets Final Cash Consideration at $2.035 Per Share in XOMA Royalty Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250273","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250273?lang=en_us&edition=fundamental","pubTime":"2025-11-26 22:00","pubTimestamp":1764165623,"startTime":"0","endTime":"0","summary":"XOMA Royalty, through its wholly-owned subsidiary, has agreed to acquire the entire issued and to be issued share capital of Mural Oncology plc. The acquisition, which follows a previous announcement made on August 20, 2025, is expected to close in early December 2025, pending satisfaction of outstanding closing conditions and approval by the Irish High Court. Further details about the transaction have been made available on Mural Oncology's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mural Oncology plc published the original content used to generate this news brief via GlobeNewswire  on November 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL8jTZ8T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","MURA","BK4585","LU2210149790.SGD","LU2095319765.USD","BK4139","BK4588","LU2210150020.SGD","BK4112","LU0314104364.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"2586250400","title":"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250400?lang=en_us&edition=fundamental","pubTime":"2025-11-26 22:00","pubTimestamp":1764165600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUA9YFMB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XOMA","MURA"],"gpt_icon":0},{"id":"2586250233","title":"Mural Oncology Plc - Total Cash Consideration of $2.035 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250233?lang=en_us&edition=fundamental","pubTime":"2025-11-26 22:00","pubTimestamp":1764165600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUA9YFMB9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MURA","XOMA","BK4139"],"gpt_icon":0},{"id":"2578268528","title":"Mural Oncology Approves Acquisition by XRA 5 Corp.","url":"https://stock-news.laohu8.com/highlight/detail?id=2578268528","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578268528?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:58","pubTimestamp":1761339531,"startTime":"0","endTime":"0","summary":"Mural Oncology Plc ( ($MURA) ) has issued an announcement. On October 24, 2025, Mural Oncology plc held a special meeting and an extraordinary gene...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mural-oncology-approves-acquisition-by-xra-5-corp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mural-oncology-approves-acquisition-by-xra-5-corp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MURA","BK4139","XRA"],"gpt_icon":0},{"id":"2578752835","title":"Mural Oncology shareholders approve acquisition by XRA 5 Corp.","url":"https://stock-news.laohu8.com/highlight/detail?id=2578752835","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578752835?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:30","pubTimestamp":1761337811,"startTime":"0","endTime":"0","summary":"Mural Oncology (MURA) announced that its shareholders have voted to approve the previously announced proposed acquisition of Mural by XRA 5 Corp., ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mural-oncology-shareholders-approve-acquisition-by-xra-5-corp-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mural-oncology-shareholders-approve-acquisition-by-xra-5-corp-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MURA","XRA"],"gpt_icon":0},{"id":"2578540603","title":"Mural Oncology plc Held Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2578540603","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578540603?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:25","pubTimestamp":1761337549,"startTime":"0","endTime":"0","summary":"Mural Oncology plc held both a Scheme Meeting and an Extraordinary General Meeting on October 24, 2025. At the Scheme Meeting, shareholders approved the scheme of arrangement. At the Extraordinary General Meeting, shareholders approved the scheme of arrangement and authorized the directors to take all necessary actions to carry the scheme into effect. All proposals presented at both meetings were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mural Oncology plc published the original content used to generate this news brief via GlobeNewswire  on October 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nNDL9kWzcd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","IE00B64PRP62.GBP","BK4139","MURA","LU2210149790.SGD","NDAQ","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BKPKM429.USD","BK4588","LU0314104364.USD"],"gpt_icon":0},{"id":"2578540601","title":"Press Release: Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty","url":"https://stock-news.laohu8.com/highlight/detail?id=2578540601","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578540601?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:25","pubTimestamp":1761337500,"startTime":"0","endTime":"0","summary":"NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. The Acquisition is expected to close in the fourth quarter of 2025, subject to customary closing conditions and the sanction of the scheme of arrangement by the High Court of Ireland.As described above, on October 24, 2025, Mural held the Scheme Meeting and EGM in Dublin, Ireland, in each case relating to the Acquisition. Both meetings were held to seek shareholder approval of the Acqui","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XOMA","MURA","XRA"],"gpt_icon":0},{"id":"2569742953","title":"Mural Oncology plc Announces Date for Shareholder Scheme Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2569742953","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569742953?lang=en_us&edition=fundamental","pubTime":"2025-09-24 07:53","pubTimestamp":1758671589,"startTime":"0","endTime":"0","summary":"Mural Oncology plc has announced that it will hold a Scheme Meeting and an Extraordinary General Meeting on October 24, 2025, at Ten Earlsfort Terrace, Dublin, Ireland. During these meetings, Mural shareholders will consider and vote on a Scheme related to an acquisition by XOMA Royalty Corporation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mural Oncology plc published the original content used to generate this news brief via GlobeNewswire  on September 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL6hMM6S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4139","BK4112","IE00BGHQF748.EUR","NDAQ","BK4585","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","XOMA","IE00B3QW5Z07.USD","MURA","LU2095319765.USD"],"gpt_icon":0},{"id":"2569742954","title":"Press Release: Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2569742954","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569742954?lang=en_us&edition=fundamental","pubTime":"2025-09-24 07:52","pubTimestamp":1758671520,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025  -- Mural Oncology plc,  , a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover Panel Act, 1997, Takeover Rules 2022 , that it has published the definitive proxy statement of Mural relating to the Acquisition described below, which also constitutes a scheme circular under Irish law  and that Mural has commenced mailing the Proxy Statement to Mural shareholders.The Proxy Statement contains important information about the Acquisition for Mural shareholders including, among other things, the full terms and conditions of the Acquisition, instructions on how Mural shareholders may attend the meetings and vote in respect of the Acquisition, information required under Section 452 of the Irish Companies Act 2014 and details of the actions to be taken by Mural shareholders in relation to the Scheme.Mural Oncology plc is a biotechnology company focused on using its protein engineering platform to devel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2569074189","title":"Mural Oncology Plc Announces Acquisition by XOMA Royalty Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2569074189","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569074189?lang=en_us&edition=fundamental","pubTime":"2025-09-24 05:51","pubTimestamp":1758664265,"startTime":"0","endTime":"0","summary":"New activity is brewing for Mural Oncology Plc ( ($MURA) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mural-oncology-plc-announces-acquisition-by-xoma-royalty-corporation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mural-oncology-plc-announces-acquisition-by-xoma-royalty-corporation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XOMA","MURA","BK4139"],"gpt_icon":0},{"id":"2564802520","title":"Mural Oncology plc Files Initial Statement of Beneficial Ownership; Trium Capital LLP Named as 10% Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2564802520","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564802520?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:18","pubTimestamp":1756815500,"startTime":"0","endTime":"0","summary":"Mural Oncology plc has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The beneficial owner named in the filing is Trium Capital LLP. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mural Oncology plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDLb7D6Np:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2560110514","title":"Mural Oncology Announces Agreement to be Acquired by XOMA Royalty for Cash Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2560110514","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560110514?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:31","pubTimestamp":1755693089,"startTime":"0","endTime":"0","summary":"Mural Oncology plc has announced its entry into an agreement to be acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty, for a cash consideration of between $2.035 and $2.24 per share. This announcement follows a strategic review process aimed at maximizing shareholder value. Mural's Board supports the transaction, and the Mural Directors, who collectively represent a small percentage of the company's shares, have agreed to vote in favor of the acquisition. The Scheme Document, containing detailed information about the acquisition and related meetings, will be published soon.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mural Oncology plc published the original content used to generate this news brief via GlobeNewswire ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL6vwZFv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4139","LU2210150020.SGD","BK4112","LU2095319765.USD","IE00B3QW5Z07.USD","NDAQ","BK4585","IE00BGHQF748.EUR","BK4588","MURA","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2560105183","title":"Mural Oncology Announces Entry Into Agreement to Be Acquired by Xra 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty for Between $2.035 and $2.24 in Cash per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2560105183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560105183?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:30","pubTimestamp":1755693001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nTUA7VZ4GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XOMA","MURA","BK4139"],"gpt_icon":0},{"id":"2560105166","title":"Mural Oncology Plc - Acquisition Values Mural at About $36.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2560105166","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560105166?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:30","pubTimestamp":1755693001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nTUA7VZ4GC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XOMA","MURA"],"gpt_icon":0},{"id":"2556381891","title":"Mural Oncology Q2 EPS $(2.78) Misses $(1.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2556381891","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556381891?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:19","pubTimestamp":1754309979,"startTime":"0","endTime":"0","summary":"Mural Oncology (NASDAQ:MURA) reported quarterly losses of $(2.78) per share which missed the analyst consensus estimate of $(1.51) by 84.11 percent. This is a 49.46 percent decrease over losses of $(1.86) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46824890/mural-oncology-q2-eps-2-78-misses-1-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MURA"],"gpt_icon":0},{"id":"2556038960","title":"Mural Oncology Reports Q2 2025 Net Loss of $48 Million, Up from $31.6 Million in Q2 2024 Due to Restructuring Charges","url":"https://stock-news.laohu8.com/highlight/detail?id=2556038960","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556038960?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:00","pubTimestamp":1754308822,"startTime":"0","endTime":"0","summary":"Mural Oncology plc  announced its financial results for the second quarter of 2025, reporting a net loss of $48.0 million, a notable increase from the $31.6 million net loss recorded in the same period in 2024. This increase was primarily due to $17.5 million in restructuring and impairment charges related to severance, lab equipment impairment, and the termination of research and development programs. As of June 30, 2025, Mural Oncology's cash and cash equivalents stood at $77.1 million. The company has provided guidance estimating cash and cash equivalents of approximately $43 million to $48 million by December 31, 2025, assuming no consummation of a transaction or strategic alternative by year-end. In a significant business update, Mural Oncology announced the discontinuation of all clinical development of its lead product candidate, nemvaleukin alfa, and the exploration of strategic alternatives to maximize shareholder value. This move includes a 90% reduction in workforce and the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL3vll5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210149790.SGD","BK4585","LU2095319765.USD","NDAQ","LU2210150020.SGD","MURA","BK4139","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}